To further investigate the impact of PD-L1 and PD-L2 expression on tumor immune microenvironment in CRC, we conducted the tumor immune infiltration analysis using both clinical datasets and tissue samples. This evidence concerns the gene PDCD1LG2 and colorectal carcinoma.